Counterfeit dental devices exist and are documented: the UK medicines and devices regulator reported seizing more than 1,900 counterfeit and non-compliant dental devices in a single year, largely handpieces, surgical equipment and drill bits. Separately, laboratory testing of counterfeit endodontic instruments has shown measurably worse fatigue resistance than the originals (PubMed 33300121). For dental implant fixtures specifically, we could not locate a published case series documenting counterfeits placed in patients, which means the accusation, wherever aimed, and the reassurance both rest on thinner evidence than either side implies. The workable response is verification rather than argument: every genuine implant carries a product reference, a lot number and a unique device identifier on its sealed sterile package, those identifiers transfer to your implant card, the supply route is evidenced by the authorised distributor's invoice, and for some brands the reference and lot can be checked against the manufacturer's own online verification tool. Those checks work the same in every country.
- 01The documented counterfeit problem in dentistry is concentrated in instruments and equipment: over 1,900 counterfeit and non-compliant dental devices seized in one year in the UK alone, per the MHRA, mostly handpieces, surgical equipment and drill bits.
- 02The one head-to-head laboratory test we could find of a counterfeit dental device against its original, rotary endodontic files, found the counterfeits failed significantly earlier under cyclic fatigue (PubMed 33300121). Appearance told the user nothing; the metallurgy differed.
- 03For implant fixtures, published documentation of counterfeits reaching patients is absent as far as we could establish. An undocumented risk is not a disproven risk; it is a reason to rely on verification rather than on anyone's assertion, in either direction.
- 04Counterfeit, clone and grey market are three different things: illegal fakes carrying another maker's branding; legal "compatible" components sold as such, which differ measurably from originals in fit and sealing (PubMed 22804848, PMID 42124290); and genuine products sold outside the authorised channel, which typically fall outside warranty territory clauses.
- 05The verification chain is procedural, not rhetorical: sealed package with REF and LOT, identifiers transferred to the implant card, authorised-distributor invoice, and where offered, the manufacturer's online reference-and-lot check. A clinic's willingness to complete it, in writing, is the actual answer to the genuineness question.
/ The claim, and the only useful way to answer it
Some overseas clinic pages argue that low implant prices abroad can only add up if a generic or unbranded fixture is substituted for the brand on the quote. The argument is aimed at Turkey often enough that a Turkish hospital writing about counterfeits has a conflict of interest, which we state here so the reader can discount for it. That is also why this page contains no counter-assertion. An assertion, ours or anyone's, is the same species of evidence as the accusation: none. What this page contains instead is what the enforcement record and the laboratory literature actually document, a set of distinctions the shouting usually flattens, and a verification procedure that resolves the question for the only implant you care about, the one in your own treatment plan, independently of who is making which claim about whom.
One framing note before the evidence. The genuineness question is usually asked as a country question, are implants in Turkey genuine, but nothing in the mechanics of counterfeiting respects borders: the seizure data below comes from the UK market, and the verification chain at the end of this page works, and is worth running, in London, Berlin and Istanbul alike. Treating verification as a special demand for foreign clinics is the mistake; it is a reasonable demand everywhere, and the implant passport guide treats it as exactly that.
/ What the enforcement record documents
Counterfeit dental devices are not hypothetical. The UK's Medicines and Healthcare products Regulatory Agency reported seizing more than 1,900 counterfeit and non-compliant dental devices in a single year, naming dental handpieces, dental surgery equipment and drill bits, and warning that substandard equipment can fracture during use and injure patients; the agency ran a joint awareness campaign with the British Dental Industry Association on the strength of it. The advice to dentists in that campaign, and in a more recent piece on the UK dental regulator's blog, is procedural rather than visual: buy from established suppliers, treat suspiciously low prices as information, verify the manufacturer's registration with the regulator, ask for certification documents, and report suspect devices through the Yellow Card scheme. The procedural emphasis is the tell: nobody involved in enforcement suggests you can recognise a fake by looking at it.
What the fakes are capable of has been measured at least once, and the result deserves more attention than it gets. A laboratory study compared original rotary endodontic files against a counterfeit version of the same system, testing design, metallurgy and mechanical performance. The counterfeits resembled the originals and even matched their nickel-titanium ratio, but their phase-transformation behaviour was the most inconsistent of the tested groups and their time to fracture under cyclic fatigue was significantly shorter (PubMed 33300121). Translated out of materials science: the fake looked right, was built of the right alloy, and still failed earliest, in a property no user could inspect. That is the entire counterfeit problem in one experiment, and it is why every serious anti-counterfeit measure in medical devices is a traceability measure, not an inspection measure.
/ What is not documented, stated plainly
Here is the part both sides of the shouting match tend to omit. The seizure records above concern instruments and equipment. For implant fixtures themselves, sterile, implantable, lot-numbered devices, we could not locate a published case series, regulatory report or peer-reviewed study documenting counterfeit fixtures placed in patients, in Turkey or anywhere else. We searched for one, because a page like this is stronger with the worst evidence on the table, and we did not find it.
Two readings of that absence are available, and both need stating. The comforting reading: implant fixtures are a harder counterfeiting target than handpieces, they are sterile-packaged, lot-tracked, sold through controlled channels to professionals rather than to the public, and the economics favour faking a thousand-euro handpiece over a fixture that must survive surgical scrutiny. The uncomfortable reading: absence of documentation is not absence of occurrence, detection would require someone to check a lot number against manufacturer records and publish the result, and undocumented does not mean impossible. We do not get to choose between those readings on evidence that thin, and neither does anyone else. What follows from the uncertainty is not a verdict but a policy: rely on the verification chain, which works regardless of which reading is true. It costs minutes, it produces documents, and it converts an unanswerable country-level argument into an answerable device-level question. The same logic drives the implant passport procedure, of which this page is effectively the adversarial reading.
/ Counterfeit, clone, grey market: three problems wearing one word
Most heat in this argument comes from three different things being called "fake", and they need separating, because their risks, legality and remedies differ.
A counterfeit is a product carrying a manufacturer's branding without being made by that manufacturer. It is illegal everywhere, it is what the seizure statistics and the endodontic-file study describe, and it is what the verification chain below exists to exclude.
A clone or "compatible" component is a legal product, sold under its own name, engineered to fit another manufacturer's system, the implant world's generic. Compatible abutments are a large, open industry; Medentika, a Straumann Group brand, builds its multi-platform line precisely on this model, and legitimate compatible parts are labelled as such. The clinical caveat is that compatibility is not identity: laboratory comparisons find non-original abutments differ in connecting-surface design with higher rotational misfit and warn of unexpected failure modes (PubMed 22804848), and a 2026 interface study measured significantly greater microleakage and torque loss against originals (PMID 42124290). In-vitro findings are not clinical outcomes, but the published implant warranties do not wait for that debate: every major manufacturer's terms are voided by mixing components, as documented clause by clause in the warranty portability guide. A quote that prices a branded fixture with an unbranded "compatible" abutment is legal, and it is also a different product than the brand name on the quote implies, which is why line-item quotes matter.
A grey-market product is genuine but bought outside the authorised distribution channel. The device is real; what breaks is the paper: manufacturer guarantees such as Straumann's and Medentika's apply to products "sold by an affiliated company or an official distributor", so the grey route can cost the warranty while leaving the titanium identical. The remedy is the invoice, not a microscope.
/ The traceability system that already exists
The reassuring fact underneath this whole subject is that implantable devices already live inside one of the tightest traceability regimes in manufacturing, and patients are entitled to its outputs. Under the EU Medical Device Regulation, every device carries a unique device identifier, and Article 18 obliges the manufacturer to deliver an implant card carrying the device name, serial or lot number and UDI, and obliges the treating institution to hand that card to the patient; dental implants are explicitly not in the exemption list. The UDI exists, in the regulation's own recitals, partly "to fight against falsified devices". For devices on the US market, the identifiers are publicly searchable: AccessGUDID, run by the FDA and the National Library of Medicine, lets anyone look up a UDI and read the manufacturer's registered device data.
On top of the regulatory layer, some manufacturers add their own: Straumann operates an online verification tool that takes a product reference and lot number and confirms whether the component is an original Straumann product, and treats that confirmation as a precondition of its guarantee; the tool sits in the professional section of its site, so the practical route is to ask the clinic to run it and show the result. Where a brand offers no public lot check, the chain does not collapse, it simply rests on the regulatory links: package, card, invoice, and, if ever needed, a written inquiry to the manufacturer's local subsidiary, which can check any lot against production records. The per-brand documentation habits, which brands publish passports, which publish verification tools, are noted in each brand guide, from Straumann and Neodent to Osstem, Ankylos, Astra Tech and Nobel Biocare.
/ The verification chain, run as a patient
Everything above compresses into four checks, each producing a document you keep. Ask, in writing and before booking, which product line will be used, exactly, line and platform, not just the brand. At surgery, ask to see or have photographed the sealed sterile package, printed with the REF and LOT; an implant does not arrive loose. Confirm the lot sticker is transferred into your record and onto your implant card, for the fixture and the abutment. Ask for the supply evidence, the authorised-distributor invoice trail, and, where the manufacturer offers a verification tool, ask the clinic to run the reference and lot through it and give you the result.
Then apply the same discipline to the arithmetic that started the argument. The direct answer to "how can it be this cheap" is a line-item quote: fixture, abutment, crown, laboratory work, imaging, and the ancillary procedures priced separately, the structure set out in the 2026 implant pricing overview and, for this hospital, published on the dental implant treatment page. Cost differences between countries sit overwhelmingly in labour, facility overhead and laboratory cost, not inside the sealed blister, and a breakdown makes that visible. The red flag, in any country, is not a low number; it is a number that cannot be broken down, on a quote that names no product line, from a clinic that will not show a lot sticker. Conversely, a clinic that completes all four checks without friction has answered the genuineness question in the only durable form, paper with numbers on it. Ours are answerable for exactly that, by name, on the clinical team page, and in writing through the contact page; what happens to those documents after you fly home is the subject of the aftercare guide.
Let’s plan the right treatment together.
Free Assessment→- 1.MHRA press release, "Dodgy dental equipment could come back to bite you", 7 October 2016 (1,900+ counterfeit and non-compliant dental devices seized in one year; device types; bona fide supplier advice)
- 2.General Dental Council blog (Adam Stanley, BDIA), "Avoiding the dangers of counterfeit and non-compliant dental products", 5 December 2025 (established suppliers, price scrutiny, MHRA registration check, certification documents, Yellow Card reporting)
- 3.Martins JNR, Silva EJNL, Marques D, et al. Comparison of design, metallurgy, mechanical performance and shaping ability of replica-like and counterfeit instruments of the ProTaper Next system. Int Endod J. 2021;54(5):780-792
- 4.Gigandet M, Bigolin G, Faoro F, Bürgin W, Brägger U. Implants with original and non-original abutment connections. Clin Implant Dent Relat Res. 2014;16(2):303-311
- 5.Sánchez-Benito F, Castells-Mira E, Cosin-Villanueva M, Gil-Loscos F, López-Roldán A. Microleakage and torque loss at the implant-abutment interface in original versus non-original abutments: an in vitro study. Materials (Basel). 2026;19(9):1884
- 6.Regulation (EU) 2017/745 on medical devices, Article 18 (implant card) and Article 27 with recitals (UDI system, including its role against falsified devices)
- 7.AccessGUDID, U.S. National Library of Medicine / FDA public UDI database
- 8.Straumann Online Verification Tool (authenticity check by product reference and lot number; guarantee precondition)
- 9.Straumann Guarantee form 152.360 and Medentika Guarantee Certificate PM05_00_0002 (authorised affiliate/distributor territory clauses)


